• Return to Headlines

29.8% Return Seen to Date on SmarTrend Acorda Therapeutics Call (ACOR)

By Amy Schwartz

SmarTrend identified a Downtrend for Acorda Therapeutics (NASDAQ:ACOR) on March 24th, 2017 at $25.35. In approximately 3 months, Acorda Therapeutics has returned 29.78% as of today's recent price of $17.80.

Over the past year, Acorda Therapeutics has traded in a range of $13.60 to $43.63 and is now at $17.80, 31% above that low. The 200-day and 50-day moving averages have moved 0.53% lower and 2.2% lower over the past week, respectively.

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Acorda Therapeutics.

Log in and add Acorda Therapeutics (ACOR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights acorda therapeutics

Ticker(s): ACOR